ClinicalTrials.gg
Not yet recruitingNCT07906210Updated Oct 30, 2026

Therapeutic Holding Versus Traditional Restraint During Pediatric Venipuncture

An interventional study of Therapeutic Holding and Traditional Restraint in Pediatric Venipuncture, sponsored by University of Baghdad. Not yet recruiting. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by University of Baghdad · Not applicable, Interventional, and Supportive care

Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Non-randomized
Ages
3 Years to 6 Years
Sex
All
01

Study summary

This study will compare therapeutic holding with traditional restraint during blood-draw venipuncture in children aged 3 to 6 years. The study will include 64 children who require venous blood sampling for routine diagnostic testing.

Children will be assigned to one of two groups using a predetermined non-random allocation method. In the therapeutic holding group, the child will sit upright on a parent's or caregiver's lap in a chest-to-chest straddle position. The caregiver will hold the child securely and comfortably while the arm used for venipuncture is safely stabilized. In the traditional restraint group, the child will lie on their back and receive the usual physical stabilization used during venipuncture by a parent, nurse, or assistant.

The study will assess children's behavioral distress, pulse rate, respiratory rate, and oxygen saturation before, during, and after venipuncture. It will also record whether blood collection is successful on the first needle insertion and the total number of attempts needed.

The purpose of the study is to determine whether therapeutic holding is associated with lower behavioral distress, greater stability of vital signs, and a higher rate of successful first-stick venipuncture compared with traditional restraint.

02

Conditions studied

  • Pediatric Venipuncture

Keywords

  • Therapeutic Holding
  • Traditional Restraint
  • Pediatric Venipuncture
  • Procedural Distress
  • Vital Signs
  • First-Stick Success
  • Children
03

In context

Lead sponsor

University of Baghdad is the lead sponsor of 169 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children aged 3-6 years.
  2. Children requiring peripheral blood-draw venipuncture for diagnostic laboratory investigations at the study setting.
  3. Children who are clinically stable before the procedure and able to undergo routine blood-draw venipuncture.
  4. Presence of a parent or legal guardian and their consent to the child's participation in the study.

Exclusion criteria

Exclusion Criteria

  1. Children whose parent or legal guardian declines participation, or whose scheduled blood-draw venipuncture is cancelled or refused before the procedure.
  2. Children with neurological, developmental, cognitive, visual, or hearing conditions that may interfere with behavioral assessment or participation in the study procedure.
  3. Children who have received sedative, analgesic, or anxiolytic medication within the preceding 24 hours.
  4. Children with acute clinical instability or conditions requiring urgent intervention that may substantially affect pulse rate, respiratory rate, or oxygen saturation.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Therapeutic Holding

    Children assigned to this arm will undergo clinically indicated venipuncture while positioned upright on a parent's or caregiver's lap in a chest-to-chest straddle position. The caregiver will hold the child securely and comfortably, control the free arm, and help maintain the venipuncture arm in a safe and stable position during blood collection.

    Procedure: Therapeutic Holding

  • Active comparator
    Traditional Restraint

    Children assigned to this arm will undergo clinically indicated venipuncture using the traditional restraint method routinely used at the study setting. The child will generally be positioned supine, with the body physically stabilized by a parent, nurse, or assistant while the selected arm is safely extended and stabilized for blood collection.

    Procedure: Traditional Restraint

Interventions

  • ProcedureTherapeutic Holding

    Therapeutic holding will be applied using a chest-to-chest straddle position. The child will sit upright on a parent's or caregiver's lap while facing the caregiver. The caregiver will hold the child's trunk securely and comfortably, control the free arm, and maintain the venipuncture arm in a safe and stable position to allow blood collection.

  • ProcedureTraditional Restraint

    Traditional restraint will be performed using the usual restraint method during venipuncture at the study setting. The child will generally be positioned supine on the procedure table, with the body physically stabilized by a parent, nurse, or assistant. The selected arm will be extended and safely stabilized during blood collection.

06

What researchers measure

Primary outcomes

  1. Behavioral Distress Across Venipuncture Phases Measured by the PBRS-R

    Children's behavioral distress will be assessed using the Procedure Behavior Rating Scale-Revised (PBRS-R). Eleven observable distress behaviors are recorded as present or absent across three procedural phases. The total PBRS-R score ranges from 0 to 33, with higher scores indicating greater behavioral distress.

    Time frame: Before positioning and before needle insertion; at needle insertion; and after needle removal and completion of venipuncture.

  2. Pulse Rate Across Venipuncture Phases

    Pulse rate, measured in beats per minute using a pulse oximeter, will be recorded to assess physiological response and stability across the procedural phases.

    Time frame: Before application of the assigned holding/restraint method; during venipuncture; and after completion of venipuncture.

  3. Respiratory Rate Across Venipuncture Phases

    Respiratory rate, measured in breaths per minute by direct observation, will be recorded to assess physiological response and stability across the procedural phases.

    Time frame: Before application of the assigned holding/restraint method; during venipuncture; and after completion of venipuncture.

  4. Oxygen Saturation (SpO₂) Across Venipuncture Phases

    Peripheral oxygen saturation (SpO₂), expressed as a percentage and measured using a pulse oximeter, will be recorded to assess physiological response and stability across the procedural phases.

    Time frame: Before application of the assigned holding/restraint method; during venipuncture; and after completion of venipuncture.

  5. First-Stick Venipuncture Success

    First-stick venipuncture success is defined as obtaining the required blood sample following the first needle penetration of the skin. The number of attempts will also be recorded. Each new needle penetration through the skin will be considered a new attempt, whereas redirection of the needle while it remains beneath the skin will not be considered an additional attempt.

    Time frame: During the venipuncture procedure.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers. Participant data will be maintained confidentially in accordance with the study protocol and institutional ethical requirements.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07906210
Responsible party
Hasanain dawood salman (MSc Candidate in Pediatric Nursing, University of Baghdad) — Principal investigator
First posted
Oct 30, 2026
Start date
Dec 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

Hasanain D Salman
Contact
hasanein.dawood2504m@conursing.uobaghdad.edu.iq
+9647829198804
Adraa H Shawq, PhD
Contact
Adraa H Shawq, PhD
principal investigator · University of Baghdad, College of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion